Skip to main content
SpringerLink
Log in

Gastrointestinal Health and Healthy Aging

  • Chapter
  • First Online:
Book cover Healthy Aging

  • 2124 Accesses

Abstract

Gastrointestinal (GI) disorders are common in older adults. Age-related changes in gastrointestinal function and an increase in the prevalence of diseases that impact gastrointestinal function, including diabetes and polypharmacy, all play a role. US census data from 2005 revealed that approximately 50% of people over the age of 65 had at least one GI complaint severe enough to merit an annual medical visit [1]. In the United States, the number of residents aged 65 years or older will double from the current 47 million to more than 90 million in 2060 [2]. These demographic changes will result in an increasing number of GI disorders requiring care. Common GI problems seen in older adults include swallowing disorders, reflux disease, constipation, pill esophagitis, peptic ulcer disease, gallbladder disease, diverticular disease, nonalcoholic fatty liver disease, and GI cancers. In this chapter, we will address approaches which promote healthy aging by preventing, identifying, and treating common GI complaints in older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. He W, Sengupta M, Velkoff VA, DeBarros KA. 65+ in the United States: 2005. Citeseer; 2005.

    Google Scholar 

  2. Ortman JM, Velkoff VA, Hogan H. An aging nation: the older population in the United States. United States Census Bureau, Economics and Statistics Administration, US Department of Commerce; 2014.

    Google Scholar 

  3. Russell RM. Changes in gastrointestinal function attributed to aging. Am J Clin Nutr. 1992;55:1203S–7S.

    Article  CAS  PubMed  Google Scholar 

  4. Ship JA, Pillemer SR, Baum BJ. Xerostomia and the geriatric patient. J Am Geriatr Soc. 2002;50:535–43.

    Article  PubMed  Google Scholar 

  5. El-Serag H, Sonnenberg A. Associations between different forms of gastro-oesophageal reflux disease. Gut. 1997;41:594–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mold JW, et al. Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol. 1991;86:965–70.

    CAS  PubMed  Google Scholar 

  7. Ruigomez A, et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther. 2004;20:751–60.

    Article  CAS  PubMed  Google Scholar 

  8. Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology. 2004;126:660–4.

    Article  PubMed  Google Scholar 

  9. Lee J, et al. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease. Clin Gastroenterol Hepatol. 2007;5:1392–8.

    Article  PubMed  Google Scholar 

  10. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol. 1999;34:20–8.

    Article  Google Scholar 

  11. Khan TA, Shragge B, Crispin J, Lind J. Esophageal motility in the elderly. Am J Dig Dis. 1977;22:1049–54.

    Article  CAS  PubMed  Google Scholar 

  12. Stilson WL, Sanders I, Gardiner G, Gorman HC, Lodge DF. Hiatal hernia and gastroesophageal reflux: a clinicoradiological analysis of more than 1,000 cases. Radiology. 1969;93:1323–7.

    Article  CAS  PubMed  Google Scholar 

  13. Achem AC, Achem SR, Stark ME, DeVault KR. Failure of esophageal peristalsis in older patients: association with esophageal acid exposure. Am J Gastroenterol. 2003;98:35.

    Article  PubMed  Google Scholar 

  14. Richter JE, Castell DO. Gastroesophageal reflux: pathogenesis, diagnosis, and therapy. Ann Intern Med. 1982;97:93–103.

    Article  CAS  PubMed  Google Scholar 

  15. Lee SD, Keum B, Chun HJ, Bak Y-T. Gastroesophageal reflux disease in type II diabetes mellitus with or without peripheral neuropathy. J Neurogastroenterol Motil. 2011;17:274.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Maeda T, Nagata K, Satoh Y, Yamazaki T, Takano D. High prevalence of gastroesophageal reflux disease in Parkinson’s disease: a questionnaire-based study. Parkinsons Dis. 2013;2013:742128.

    PubMed  PubMed Central  Google Scholar 

  17. El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53:2307–12.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Pointner R. Surgical principles of minimally invasive procedures: Springer; 2017. p. 47–51.

    Google Scholar 

  19. Philpott H, Nandurkar S, Lubel J, Gibson P. Drug-induced gastrointestinal disorders. Frontline Gastroenterol. 2014;5:49–57.

    Article  CAS  PubMed  Google Scholar 

  20. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308.

    Article  PubMed  Google Scholar 

  21. Roman S, et al. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017;29:1–15.

    Article  CAS  PubMed  Google Scholar 

  22. Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013;10:371.

    Article  CAS  PubMed  Google Scholar 

  23. Poh CH, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc. 2010;71:28–34.

    Article  PubMed  Google Scholar 

  24. Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1383–1391. e1385.

    Article  PubMed  Google Scholar 

  25. Leiman D, et al. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis. Dis Esophagus. 2017;30:1–8.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Savarino E, et al. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD). Expert Opin Pharmacother. 2017;18:1333–43.

    Article  CAS  PubMed  Google Scholar 

  27. Richter JE, et al. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 1996;91:1766–72.

    CAS  PubMed  Google Scholar 

  28. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. https://doi.org/10.3322/caac.20138.

    Article  PubMed  Google Scholar 

  29. Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012;62:118–28. https://doi.org/10.3322/caac.20141.

    Article  PubMed  Google Scholar 

  30. Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. https://doi.org/10.3322/caac.20107.

    Article  PubMed  Google Scholar 

  31. Engel LS, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404–13.

    Article  PubMed  Google Scholar 

  32. Hur C, et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119:1149–58. https://doi.org/10.1002/cncr.27834.

    Article  PubMed  Google Scholar 

  33. Polednak AP. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer. 2003;105:98–100. https://doi.org/10.1002/ijc.11029.

    Article  CAS  PubMed  Google Scholar 

  34. Won E, Ilson DH. Management of localized esophageal cancer in the older patient. Oncologist. 2014;19:367–74. https://doi.org/10.1634/theoncologist.2013-0178.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet (London, England). 2013;381:400–12. https://doi.org/10.1016/s0140-6736(12)60643-6.

    Article  Google Scholar 

  36. Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2014;371:2499–509.

    Article  PubMed  CAS  Google Scholar 

  37. Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2014;64:381–7. https://doi.org/10.1136/gutjnl-2014-308124.

    Article  PubMed  Google Scholar 

  38. Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21:7933–43. https://doi.org/10.3748/wjg.v21.i26.7933.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Appelqvist P, Salmo M. Lye corrosion carcinoma of the esophagus: a review of 63 cases. Cancer. 1980;45:2655–8.

    Article  CAS  PubMed  Google Scholar 

  40. Sandler RS, et al. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA. 1995;274:1359–62.

    Article  CAS  PubMed  Google Scholar 

  41. Fogh SE, et al. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy? Int J Radiat Oncol Biol Phys. 2011;80:1372–6. https://doi.org/10.1016/j.ijrobp.2010.04.055.

    Article  PubMed  Google Scholar 

  42. Rubenstein JH, Taylor JB. Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2010;32:1222–7. https://doi.org/10.1111/j.1365-2036.2010.04471.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM. Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology. 2002;122:26–33.

    Article  PubMed  Google Scholar 

  44. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–91. https://doi.org/10.1053/j.gastro.2011.01.030.

    Article  PubMed  Google Scholar 

  45. Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett’s oesophagus: a systematic review and meta-analysis. Gut. 2014;63:1229–37. https://doi.org/10.1136/gutjnl-2013-305997.

    Article  PubMed  Google Scholar 

  46. Ferguson MK, Durkin A. Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg. 2002;6:29–36.

    Article  PubMed  Google Scholar 

  47. Incarbone R, Bonavina L, Saino G, Bona D, Peracchia A. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett’s esophagus. Surg Endosc. 2002;16:263–6.

    Article  CAS  PubMed  Google Scholar 

  48. van Sandick JW, et al. Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma. Gut. 1998;43:216–22.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Peters JH, et al. Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg. 1994;108:813–22.

    CAS  PubMed  Google Scholar 

  50. Gómez V, Xiao S-Y. Alendronate-induced esophagitis in an elderly woman. Int J Clin Exp Pathol. 2009;2:200.

    PubMed  Google Scholar 

  51. Carlborg B, Kumlien A, Olsson H. Drug-induced esophageal strictures. Lakartidningen. 1978;75:4609–11.

    CAS  PubMed  Google Scholar 

  52. Hey H, Jorgensen F, Sorensen K, Hasselbalch H, Wamberg T. Oesophageal transit of six commonly used tablets and capsules. Br Med J (Clin Res Ed). 1982;285:1717–9.

    Article  CAS  Google Scholar 

  53. Semble EL, Wu WC, Castell DO. Nonsteroidal antiinflammatory drugs and esophageal injury. Semin Arthritis Rheum. 1989;19:99–109.

    Article  CAS  PubMed  Google Scholar 

  54. Abid S, et al. Pill-induced esophageal injury: endoscopic features and clinical outcomes. Endoscopy. 2005;37:740–4. https://doi.org/10.1055/s-2005-870129.

    Article  CAS  PubMed  Google Scholar 

  55. Bott S, Prakash C, McCallum RW. Medication-induced esophageal injury: survey of the literature. Am J Gastroenterol. 1987;82:758–63.

    CAS  PubMed  Google Scholar 

  56. Franceschi M, Di Mario F, Leandro G, Maggi S, Pilotto A. Acid-related disorders in the elderly. Best Pract Res Clin Gastroenterol. 2009;23:839–48.

    Article  CAS  PubMed  Google Scholar 

  57. Higham J, Kang J, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut. 2002;50:460–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Pilotto A, et al. Effect of age on gastric acid, pepsin, pepsinogen group A and gastrin secretion in peptic ulcer patients. Gerontology. 1994;40:253–9.

    Article  CAS  PubMed  Google Scholar 

  59. Pilotto A. Aging and upper gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 2004;18:73–81.

    Article  PubMed  Google Scholar 

  60. Linder JD, Wilcox CM. Acid peptic disease in the elderly. Gastroenterol Clin. 2001;30:363–76.

    Article  CAS  Google Scholar 

  61. Seinelä L, Ahvenainen J. Peptic ulcer in the very old patients. Gerontology. 2000;46:271–5.

    Article  PubMed  Google Scholar 

  62. Kemppainen H, Räihä I, Sourander L. Clinical presentation of peptic ulcer in the elderly. Gerontology. 1997;43:283–8.

    Article  CAS  PubMed  Google Scholar 

  63. Moayyedi PM, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017;112:988.

    Article  CAS  PubMed  Google Scholar 

  64. Birk JW, Soriano M. Stress ulcer prophylaxis in the nonintensive care unit hospitalized patient: physician prescribing behaviors. South Med J. 2010;103:1195. https://doi.org/10.1097/SMJ.0b013e3181fb7efd.

    Article  PubMed  Google Scholar 

  65. Rotman SR, Bishop TF. Proton pump inhibitor use in the US ambulatory setting, 2002–2009. PLoS One. 2013;8:e56060.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf. 2017;8:273–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. O’mahony D, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.

    Article  PubMed  Google Scholar 

  68. Lewis JR, et al. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study. J Bone Miner Res. 2014;29:2489–97.

    Article  PubMed  Google Scholar 

  69. O’Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. 2005;118:778–81.

    Article  PubMed  CAS  Google Scholar 

  70. Maggio M, et al. Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals. Bone. 2013;57:437–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Eom C-S, Park SM, Myung S-K, Yun JM, Ahn J-S. Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies. Ann Fam Med. 2011;9:257–67.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies. Am J Gastroenterol. 2011;106:1209.

    Article  CAS  PubMed  Google Scholar 

  73. Ye X, et al. Proton pump inhibitors therapy and risk of hip fracture: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2011;23:794–800.

    Article  CAS  PubMed  Google Scholar 

  74. Elaine WY, Bauer SR, Bain PA, Bauer DC. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med. 2011;124:519–26.

    Article  CAS  Google Scholar 

  75. DePestel DD, Aronoff DM. Epidemiology of Clostridium difficile infection. J Pharm Pract. 2013;26:464–75.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Deshpande A, et al. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:225–33.

    Article  CAS  PubMed  Google Scholar 

  77. Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol. 2012;107:1001.

    Article  CAS  PubMed  Google Scholar 

  78. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. https://doi.org/10.3322/caac.21208.

    Article  PubMed  Google Scholar 

  79. Zali H, Rezaei-Tavirani M, Azodi M. Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench. 2011;4:175.

    PubMed  PubMed Central  Google Scholar 

  80. Valle J, Seppälä K, Sipponen P, Kosunen T. Disappearance of gastritis after eradication of Helicobacter pylori: a morphometric study. Scand J Gastroenterol. 1991;26:1057–65.

    Article  CAS  PubMed  Google Scholar 

  81. Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25–40. https://doi.org/10.15430/jcp.2015.20.1.25.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Kratzer W, et al. Gallstone prevalence in Germany: the Ulm Gallbladder Stone Study. Dig Dis Sci. 1998;43:1285–91.

    Article  CAS  PubMed  Google Scholar 

  83. Jorgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol. 1987;126:912–21.

    Article  CAS  PubMed  Google Scholar 

  84. Montalto G, et al. Prevalence of biliary lithiasis in the elderly people of a small town in Sicily. Age Ageing. 1992;21:338–42.

    Article  CAS  PubMed  Google Scholar 

  85. Coelho JC, et al. Prevalence of gallstones in a Brazilian population. Int Surg. 1999;84:25–8.

    CAS  PubMed  Google Scholar 

  86. Ross SO, Forsmark CE. Pancreatic and biliary disorders in the elderly. Gastroenterol Clin North Am. 2001;30:531–545, x.

    Article  CAS  PubMed  Google Scholar 

  87. EASL. Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol. 2016;65:146–81. https://doi.org/10.1016/j.jhep.2016.03.005.

    Article  Google Scholar 

  88. Agrusa A, et al. Role and outcomes of laparoscopic cholecystectomy in the elderly. Int J Surg (London, England). 2014;12 Suppl 2:S37–s39. https://doi.org/10.1016/j.ijsu.2014.08.385.

    Article  Google Scholar 

  89. Ambe PC, Weber SA, Christ H, Wassenberg D. Primary cholecystectomy is feasible in elderly patients with acute cholecystitis. Aging Clin Exp Res. 2015;27:921–6. https://doi.org/10.1007/s40520-015-0361-0.

    Article  PubMed  Google Scholar 

  90. Lee SI, Na BG, Yoo YS, Mun SP, Choi NK. Clinical outcome for laparoscopic cholecystectomy in extremely elderly patients. Ann Surg Treat Res. 2015;88:145–51. https://doi.org/10.4174/astr.2015.88.3.145.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Dubecz A, et al. Cholecystectomy in the very elderly--is 90 the new 70? J Gastrointest Surg. 2012;16:282–5. https://doi.org/10.1007/s11605-011-1708-2.

    Article  PubMed  Google Scholar 

  92. Nielsen LB, Harboe KM, Bardram L. Cholecystectomy for the elderly: no hesitation for otherwise healthy patients. Surg Endosc. 2014;28:171–7. https://doi.org/10.1007/s00464-013-3144-8.

    Article  PubMed  Google Scholar 

  93. Haltmeier T, Benjamin E, Inaba K, Lam L, Demetriades D. Early versus delayed same-admission laparoscopic cholecystectomy for acute cholecystitis in elderly patients with comorbidities. J Trauma Acute Care Surg. 2015;78:801–7. https://doi.org/10.1097/ta.0000000000000577.

    Article  PubMed  Google Scholar 

  94. Ferrarese AG, et al. Elective and emergency laparoscopic cholecystectomy in the elderly: our experience. BMC Surg. 2013;13 Suppl 2:S21. https://doi.org/10.1186/1471-2482-13-s2-s21.

    Article  PubMed  Google Scholar 

  95. Kuwabara K, et al. Relationships of age, cholecystectomy approach and timing with the surgical and functional outcomes of elderly patients with cholecystitis. Int J Surg (London, England). 2011;9:392–9. https://doi.org/10.1016/j.ijsu.2011.03.026.

    Article  Google Scholar 

  96. Howard JM, Hanly AM, Keogan M, Ryan M, Reynolds JV. Percutaneous cholecystostomy--a safe option in the management of acute biliary sepsis in the elderly. Int J Surg (London, England). 2009;7:94–9. https://doi.org/10.1016/j.ijsu.2009.01.002.

    Article  CAS  Google Scholar 

  97. Jang WS, et al. Outcome of conservative percutaneous cholecystostomy in high-risk patients with acute cholecystitis and risk factors leading to surgery. Surg Endosc. 2015;29:2359–64. https://doi.org/10.1007/s00464-014-3961-4.

    Article  PubMed  Google Scholar 

  98. Na BG, et al. The safety and efficacy of percutaneous transhepatic gallbladder drainage in elderly patients with acute cholecystitis before laparoscopic cholecystectomy. Ann Surg Treat Res. 2015;89:68–73. https://doi.org/10.4174/astr.2015.89.2.68.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Maekawa S, et al. Endoscopic gallbladder stenting for acute cholecystitis: a retrospective study of 46 elderly patients aged 65 years or older. BMC Gastroenterol. 2013;13:65. https://doi.org/10.1186/1471-230x-13-65.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Venneman NG, et al. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. Hepatology (Baltimore, Md.). 2006;43:1276–83.

    Article  CAS  Google Scholar 

  101. Tanaka G, Nakahara Y, Nakazima Y. Japanese reference man 1988-IV. Studies on the weight and size of internal organs of Normal Japanese. Nihon Igaku Hoshasen Gakkai zasshi. Nippon Acta Radiologica. 1989;49:344–64.

    CAS  PubMed  Google Scholar 

  102. Matsuda Y. Age-related pathological changes in the pancreas. Front Biosci (Elite Ed). 2018;10:137–42.

    Article  Google Scholar 

  103. Zhang J, Dhakal I, Ning B, Kesteloot H. Patterns and trends of pancreatic cancer mortality rates in Arkansas, 1969-2002: a comparison with the US population. Eur J Cancer Prev. 2008;17:18–27. https://doi.org/10.1097/CEJ.0b013e32809b4ccd.

    Article  PubMed  Google Scholar 

  104. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. https://doi.org/10.3322/caac.21254.

    Article  PubMed  Google Scholar 

  105. Sohn TA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788–97; discussion 797–789.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Tanaka M, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–53.

    Article  PubMed  Google Scholar 

  107. Elta GH, Enestvedt BK, Sauer BG, Lennon AM. ACG clinical guideline: diagnosis and management of pancreatic cysts. Am J Gastroenterol. 2018;113:464.

    Article  PubMed  Google Scholar 

  108. Vege SS, et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:819–22.

    Article  PubMed  Google Scholar 

  109. Kamisawa T, et al. Chronic pancreatitis in the elderly in Japan. Pancreatology. 2004;4:223–7; discussion 227–8. https://doi.org/10.1159/000078433.

    Article  PubMed  Google Scholar 

  110. Gordon-Dseagu VL, Devesa SS, Goggins M, Stolzenberg-Solomon R. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Int J Epidemiol. 2017;47:427–39.

    Article  PubMed Central  Google Scholar 

  111. Force U. P. T. Guide to clinical preventive services, Alexandria, VA: International Medical Publishing; 1996.

    Google Scholar 

  112. Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061–7. https://doi.org/10.1056/nejm199912303412706.

    Article  CAS  PubMed  Google Scholar 

  113. Sharma A, Kandlakunta H, Nagpal SJS, Feng Z, Hoos W, Petersen GM, Chari ST. Model to determine risk of pancreatic cancer in patients with new-onset diabetes. Gastroenterology. 2018;155:730–739.e3.

    Article  PubMed  Google Scholar 

  114. Holt PR, Balint JA. Effects of aging on intestinal lipid absorption. Am J Physiol. 1993;264:G1–6.

    CAS  PubMed  Google Scholar 

  115. D’Souza AL. Ageing and the gut. Postgrad Med J. 2007;83:44–53. https://doi.org/10.1136/pgmj.2006.049361.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Amer S. Small intestinal bacterial overgrowth in the elderly: an often missed entity. Indian J Gerontol. 2015;29:387–97.

    Google Scholar 

  117. Peery AF, et al. A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology. 2012;142:266–272.e261. https://doi.org/10.1053/j.gastro.2011.10.035.

    Article  PubMed  Google Scholar 

  118. Painter NS, Burkitt DP. Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol. 1975;4:3–21.

    CAS  PubMed  Google Scholar 

  119. Peery AF, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179–87. e1171–3. https://doi.org/10.1053/j.gastro.2012.08.002.

    Article  PubMed  Google Scholar 

  120. Meyers MA, Alonso DR, Gray GF, Baer JW. Pathogenesis of bleeding colonic diverticulosis. Gastroenterology. 1976;71:577–83.

    CAS  PubMed  Google Scholar 

  121. Collins D, Winter DC. Modern concepts in diverticular disease. J Clin Gastroenterol. 2015;49:358–69. https://doi.org/10.1097/mcg.0000000000000308.

    Article  PubMed  Google Scholar 

  122. Gear JS, et al. Symptomless diverticular disease and intake of dietary fibre. Lancet. 1979;1:511–4.

    Article  CAS  PubMed  Google Scholar 

  123. Schlotthauer HL. Familial diverticulosis of the colon; report of seven cases in one family of nine persons. Ann Surg. 1946;124:497–502.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Matrana MR, Margolin DA. Epidemiology and pathophysiology of diverticular disease. Clin Colon Rectal Surg. 2009;22:141–6. https://doi.org/10.1055/s-0029-1236157.

    Article  PubMed  PubMed Central  Google Scholar 

  125. DiSiena MS, Birk JW. Diverticular disease: the old, the new, and the ever-changing view. South Med J. 2018;111:144–50.

    Article  PubMed  Google Scholar 

  126. Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol. 1975;4:53–69.

    CAS  PubMed  Google Scholar 

  127. Schechter S, Mulvey J, Eisenstat TE. Management of uncomplicated acute diverticulitis: results of a survey. Dis Colon Rectum. 1999;42:470–5; discussion 475–6.

    Article  CAS  PubMed  Google Scholar 

  128. Salzman H, Lillie D. Diverticular disease: diagnosis and treatment. Am Fam Physician. 2005;72:1229–34.

    PubMed  Google Scholar 

  129. Jensen DM, Machicado GA, Jutabha R, Kovacs TO. Urgent colonoscopy for the diagnosis and treatment of severe diverticular hemorrhage. N Engl J Med. 2000;342:78–82. https://doi.org/10.1056/nejm200001133420202.

    Article  CAS  PubMed  Google Scholar 

  130. Zuccaro G Jr. Management of the adult patient with acute lower gastrointestinal bleeding. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol. 1998;93:1202–8. https://doi.org/10.1111/j.1572-0241.1998.00395.x.

    Article  PubMed  Google Scholar 

  131. Browder W, Cerise EJ, Litwin MS. Impact of emergency angiography in massive lower gastrointestinal bleeding. Ann Surg. 1986;204:530–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. McGuire HH Jr. Bleeding colonic diverticula. A reappraisal of natural history and management. Ann Surg. 1994;220:653–6.

    Article  PubMed  PubMed Central  Google Scholar 

  133. Parkes BM, Obeid FN, Sorensen VJ, Horst HM, Fath JJ. The management of massive lower gastrointestinal bleeding. Am Surg. 1993;59:676–8.

    CAS  PubMed  Google Scholar 

  134. Crowe FL, Appleby PN, Allen NE, Key TJ. Diet and risk of diverticular disease in Oxford cohort of European Prospective Investigation into Cancer and Nutrition (EPIC): prospective study of British vegetarians and non-vegetarians. BMJ. 2011;343:d4131. https://doi.org/10.1136/bmj.d4131.

    Article  PubMed  PubMed Central  Google Scholar 

  135. Gear J, et al. Symptomless diverticular disease and intake of dietary fibre. Lancet. 1979;313:511–4.

    Article  Google Scholar 

  136. Cao Y, et al. Meat intake and risk of diverticulitis among men. Gut. 2017;67(3) https://doi.org/10.1136/gutjnl-2016-313082.

  137. Aldoori WH, et al. A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr. 1998;128:714–9. https://doi.org/10.1093/jn/128.4.714.

    Article  CAS  PubMed  Google Scholar 

  138. Crowe FL, et al. Source of dietary fibre and diverticular disease incidence: a prospective study of UK women. Gut. 2014;63:1450–6. https://doi.org/10.1136/gutjnl-2013-304644.

    Article  PubMed  Google Scholar 

  139. Aune D, et al. Tobacco smoking and the risk of diverticular disease–a systematic review and meta-analysis of prospective studies. Color Dis. 2017;19:621–33.

    Article  CAS  Google Scholar 

  140. Strate LL, Liu YL, Aldoori WH, Giovannucci EL. Physical activity decreases diverticular complications. Am J Gastroenterol. 2009;104:1221–30. https://doi.org/10.1038/ajg.2009.121.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Islam J, et al. The role of the humoral immune response to Clostridium difficile toxins A and B in susceptibility to C. difficile infection: a case-control study. Anaerobe. 2014;27:82–6. https://doi.org/10.1016/j.anaerobe.2014.03.011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect. 2012;18(Suppl 6):21–7. https://doi.org/10.1111/1469-0691.12046.

    Article  PubMed  Google Scholar 

  143. Jump RL. Clostridium difficile infection in older adults. Aging Health. 2013;9:403–14. https://doi.org/10.2217/ahe.13.37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. McDonald LC, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66:987–94. https://doi.org/10.1093/cid/ciy149.

    Article  CAS  PubMed  Google Scholar 

  145. Silverman M, et al. Antibiotic prescribing for nonbacterial acute upper respiratory infections in elderly persons. Ann Intern Med. 2017;166:765–74. https://doi.org/10.7326/m16-1131.

    Article  PubMed  Google Scholar 

  146. Na X, Kelly C. Probiotics in clostridium difficile infection. J Clin Gastroenterol. 2011;45(Suppl):S154–8. https://doi.org/10.1097/MCG.0b013e31822ec787.

    Article  PubMed  PubMed Central  Google Scholar 

  147. Henderson M, Bragg A, Fahim G, Shah M, Hermes-DeSantis ER. A review of the safety and efficacy of vaccines as prophylaxis for clostridium difficile infections. Vaccines. 2017;5(3):pii: E25. https://doi.org/10.3390/vaccines5030025.

    Article  CAS  Google Scholar 

  148. Ginsberg DA, Phillips SE, Wallace J, Josephson KL. Evaluating and managing constipation in the elderly. Urol Nurs. 2007;27:191–200, 212; quiz 201.

    PubMed  Google Scholar 

  149. Gallegos-Orozco JF, Foxx-Orenstein AE, Sterler SM, Stoa JM. Chronic constipation in the elderly. Am J Gastroenterol. 2012;107:18–25; quiz 26. https://doi.org/10.1038/ajg.2011.349.

    Article  PubMed  Google Scholar 

  150. Bitar K, Greenwood-Van Meerveld B, Saad R, Wiley JW. Aging and gastrointestinal neuromuscular function: insights from within and outside the gut. Neurogastroenterol Motil. 2011;23:490–501. https://doi.org/10.1111/j.1365-2982.2011.01678.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  151. Simren M, Palsson OS, Whitehead WE. Update on Rome IV criteria for colorectal disorders: implications for clinical practice. Curr Gastroenterol Rep. 2017;19:15. https://doi.org/10.1007/s11894-017-0554-0.

    Article  PubMed  PubMed Central  Google Scholar 

  152. Dukas L, Willett WC, Giovannucci EL. Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women. Am J Gastroenterol. 2003;98:1790–6. https://doi.org/10.1111/j.1572-0241.2003.07591.x.

    Article  PubMed  Google Scholar 

  153. Sanjoaquin MA, Appleby PN, Spencer EA, Key TJ. Nutrition and lifestyle in relation to bowel movement frequency: a cross-sectional study of 20630 men and women in EPIC-Oxford. Public Health Nutr. 2004;7:77–83.

    Article  PubMed  Google Scholar 

  154. Yoon S-J, Chu D-C, Juneja LR. Chemical and physical properties, safety and application of partially hydrolized guar gum as dietary fiber. J Clin Biochem Nutr. 2008;42:1–7.

    Article  CAS  PubMed  Google Scholar 

  155. Attaluri A, Donahoe R, Valestin J, Brown K, Rao SSC. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther. 2011;33:822–8.

    Article  CAS  PubMed  Google Scholar 

  156. Markland AD, et al. Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol. 2013;108:796–803. https://doi.org/10.1038/ajg.2013.73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  157. Schuster BG, Kosar L, Kamrul R. Constipation in older adults: stepwise approach to keep things moving. Can Fam Physician. 2015;61:152–8.

    PubMed  PubMed Central  Google Scholar 

  158. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A. SEER cancer statistics review, 1975–2009 (vintage 2009 populations), National Cancer Institute. Bethesda, MD. 2013-07-01. http://seer.cancer.gov/staffacts/html/colorect.html. April 2012.

  159. Murphy G, et al. Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int J Cancer. 2011;128:1668–75.

    Article  CAS  PubMed  Google Scholar 

  160. Ansa BE, Coughlin SS, Alema-Mensah E, Smith SA. Evaluation of colorectal cancer incidence trends in the United States (2000-2014). J Clin Med. 2018;7(2):pii: E22. https://doi.org/10.3390/jcm7020022.

    Article  Google Scholar 

  161. Garcia-Albeniz X, Chan AT. Aspirin for the prevention of colorectal cancer. Best Pract Res Clin Gastroenterol. 2011;25:461–72. https://doi.org/10.1016/j.bpg.2011.10.015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  162. Bibbins-Domingo K. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164:836–45.

    Article  PubMed  Google Scholar 

  163. McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, Kirpach B, Shah RC, Ives DG, Storey E, Ryan J, Tonkin AM, Newman AB, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Radziszewska B, Grimm R, Murray AM, ASPREE Investigator Group. Effect of aspirin on all-cause mortality in the healthy elderly. N Engl J Med. 2018;379(16):1519–28. https://doi.org/10.1056/NEJMoa1803955.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  164. Kim IH, Kisseleva T, Brenner DA. Aging and liver disease. Curr Opin Gastroenterol. 2015;31:184–91. https://doi.org/10.1097/mog.0000000000000176.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  165. O’Malley K, Crooks J, Duke E, Stevenson IH. Effect of age and sex on human drug metabolism. Br Med J. 1971;3:607–9.

    Article  PubMed  PubMed Central  Google Scholar 

  166. Swift CG, Homeida M, Halliwell M, Roberts CJ. Antipyrine disposition and liver size in the elderly. Eur J Clin Pharmacol. 1978;14:149–52.

    Article  CAS  PubMed  Google Scholar 

  167. Poulose N, Raju R. Aging and injury: alterations in cellular energetics and organ function. Aging Dis. 2014;5:101–8. https://doi.org/10.14336/ad.2014.0500101.

    Article  PubMed  PubMed Central  Google Scholar 

  168. Sanz N, Diez-Fernandez C, Alvarez AM, Fernandez-Simon L, Cascales M. Age-related changes on parameters of experimentally-induced liver injury and regeneration. Toxicol Appl Pharmacol. 1999;154:40–9.

    Article  CAS  PubMed  Google Scholar 

  169. Poynard T, et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol. 2001;34:730–9.

    Article  CAS  PubMed  Google Scholar 

  170. Forrest EH, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut. 2005;54:1174–9. https://doi.org/10.1136/gut.2004.050781.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  171. Amarapurkar D, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007;6:161–3.

    PubMed  Google Scholar 

  172. Park SH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006;21:138–43. https://doi.org/10.1111/j.1440-1746.2005.04086.x.

    Article  PubMed  Google Scholar 

  173. Koehler EM, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol. 2012;57:1305–11. https://doi.org/10.1016/j.jhep.2012.07.028.

    Article  PubMed  Google Scholar 

  174. Barzilai N, Huffman DM, Muzumdar RH, Bartke A. The critical role of metabolic pathways in aging. Diabetes. 2012;61:1315–22. https://doi.org/10.2337/db11-1300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  175. Mahrouf-Yorgov M, et al. Increased susceptibility to liver fibrosis with age is correlated with an altered inflammatory response. Rejuvenation Res. 2011;14:353–63. https://doi.org/10.1089/rej.2010.1146.

    Article  CAS  PubMed  Google Scholar 

  176. Dixon JB, Bhathal PS, Hughes NR, O’Brien PE. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology (Baltimore, Md.). 2004;39:1647–54. https://doi.org/10.1002/hep.20251.

    Article  Google Scholar 

  177. Cholankeril G, Patel R, Khurana S, Satapathy SK. Hepatocellular carcinoma in non-alcoholic steatohepatitis: current knowledge and implications for management. World J Hepatol. 2017;9:533–43. https://doi.org/10.4254/wjh.v9.i11.533.

    Article  PubMed  PubMed Central  Google Scholar 

  178. Blazer DG, Wu LT. The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health. Am J Psychiatry. 2009;166:1162–9. https://doi.org/10.1176/appi.ajp.2009.09010016.

    Article  PubMed  PubMed Central  Google Scholar 

  179. Meier P, Seitz HK. Age, alcohol metabolism and liver disease. Curr Opin Clin Nutr Metab Care. 2008;11:21–6. https://doi.org/10.1097/MCO.0b013e3282f30564.

    Article  CAS  PubMed  Google Scholar 

  180. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet (London, England). 1997;349:825–32.

    Article  CAS  Google Scholar 

  181. McMahon BJ. Natural history of chronic hepatitis B. Clin Liver Dis. 2010;14:381–96. https://doi.org/10.1016/j.cld.2010.05.007.

    Article  PubMed  Google Scholar 

  182. Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology (Baltimore, Md.). 1998;28:805–9. https://doi.org/10.1002/hep.510280330.

    Article  CAS  Google Scholar 

  183. Westin J, Nordlinder H, Lagging M, Norkrans G, Wejstal R. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol. 2002;37:837–42.

    Article  PubMed  Google Scholar 

  184. Moyer VA. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: US preventive services task force recommendation statement. Ann Intern Med. 2013;159:210–8.

    PubMed  Google Scholar 

  185. Satre DD, Sterling SA, Mackin RS, Weisner C. Patterns of alcohol and drug use among depressed older adults seeking outpatient psychiatric services. Am J Geriatr Psychiatry. 2011;19:695–703. https://doi.org/10.1097/JGP.0b013e3181f17f0a.

    Article  PubMed  PubMed Central  Google Scholar 

  186. Chen CH, et al. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007;106:148–55. https://doi.org/10.1016/s0929-6646(09)60231-x.

    Article  PubMed  Google Scholar 

  187. Dominguez A, Bruguera M, Vidal J, Plans P, Salleras L. Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol. 2001;65:688–93.

    Article  CAS  PubMed  Google Scholar 

  188. Gramenzi A, et al. Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the liver. Dig Liver Dis. 2012;44:674–80. https://doi.org/10.1016/j.dld.2012.03.009.

    Article  PubMed  Google Scholar 

  189. Moyer VA. Screening for hepatitis C virus infection in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159:349–57.

    Article  PubMed  Google Scholar 

  190. Smith BD, et al. Hepatitis C virus testing of persons born during 1945–1965: recommendations from the Centers for Disease Control and Prevention. Ann Intern Med. 2012;157:817–22.

    Article  PubMed  PubMed Central  Google Scholar 

  191. Hellard ME, Chou R, Easterbrook P. WHO guidelines on testing for hepatitis B and C - meeting targets for testing. BMC Infect Dis. 2017;17:703. https://doi.org/10.1186/s12879-017-2765-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Connecticut School of Medicine, Farmington, CT, USA

    Pradeep K. Siddappa

  2. Division of Gastroenterology and Hepatology, University of Connecticut School of Medicine, Farmington, CT, USA

    John W. Birk

Authors
  1. Pradeep K. Siddappa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John W. Birk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John W. Birk .

Editor information

Editors and Affiliations

  1. Center on Aging and Departments of Family Medicine and Medicine, University of Connecticut School of Medicine, Farmington, CT, USA

    Patrick P. Coll

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Siddappa, P.K., Birk, J.W. (2019). Gastrointestinal Health and Healthy Aging. In: Coll, P. (eds) Healthy Aging. Springer, Cham. https://doi.org/10.1007/978-3-030-06200-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-06200-2_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-06199-9

  • Online ISBN: 978-3-030-06200-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation